Target
Isocitrate dehydrogenase [NADP] cytoplasmic [R132C]
Ligand
BDBM363689
Substrate
n/a
Meas. Tech.
In Vitro Biochemical Assay
IC50
3690±n/a nM
Citation
 Kelly, PFCollis, ADavis, JWalker, DAshwell, SThomson, BLu, W Inhibiting mutant IDH-1 US Patent  US11376246 Publication Date 7/5/2022 
Target
Name:
Isocitrate dehydrogenase [NADP] cytoplasmic [R132C]
Synonyms:
IDH1 | IDH1 R132C | IDH1(R132C) | IDHC_HUMAN | Isocitrate dehydrogenase (IDH1)(R132C) | Isocitrate dehydrogenase 1 mutant (R132C) | Isocitrate dehydrogenase [NADP] cytoplasmic (IDH1) (R132C) | PICD
Type:
Enzyme Catalytic Domain
Mol. Mass.:
46607.23
Organism:
Homo sapiens (Human)
Description:
O75874[R132C]
Residue:
414
Sequence:
MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGCHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL
  
Inhibitor
Name:
BDBM363689
Synonyms:
US10640534, Compound 176 | US10682352, Compound AG120 | US10717764, Compound 176 | US11021515, Compound 176 | US11311527, Cpd ID AG-120 | US11376246, Cpd ID AG-120 | US11576906, Compound AG-120 | US11667673, Compound 176 | US9850277, Compound 176
Type:
Small organic molecule
Emp. Form.:
C28H22ClF3N6O3
Mol. Mass.:
582.961
SMILES:
Fc1cncc(c1)N([C@H](C(=O)NC1CC(F)(F)C1)c1ccccc1Cl)C(=O)[C@@H]1CCC(=O)N1c1cc(ccn1)C#N |r|
Structure:
Search PDB for entries with ligand similarity: